Sigma-Aldrich
XYLOMETAZOLINE HCL (C005B-275379)
Biochem/physiol Actions α:-adrenoceptor agonist: imidazoline binding site ligand. Features and Benefits This compound was developed by Novartis .
Biochem/physiol Actions
α-adrenoceptor agonist; imidazoline binding site ligand.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Shipping Information:
Hazmat Fee: $65.00 + applicable shipping charges are added after the order is placed.
More Information: https://cenmed.com/shipping-returns
Specifications
- UPC:
- 51263117
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- Yes
- MPN:
- X6000-25G
- CAS:
- 1218-35-5



